Akso Health Group ADR (AHG)vsEDAP TMS SA (EDAP)
AHG
Akso Health Group ADR
$2.37
+4.37%
HEALTHCARE · Cap: $807.33M
EDAP
EDAP TMS SA
$3.91
+4.83%
HEALTHCARE · Cap: $134.99M
Smart Verdict
WallStSmart Research — data-driven comparison
EDAP TMS SA generates 332% more annual revenue ($63.80M vs $14.78M). AHG leads profitability with a 0.0% profit margin vs -30.8%. AHG earns a higher WallStSmart Score of 24/100 (F).
AHG
Avoid24
out of 100
Grade: F
EDAP
Avoid23
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
No standout strengths identified
Areas to Watch
4.2% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Smaller company, higher risk/reward
Expensive relative to growth rate
ROE of -59.5% — below average capital efficiency
Earnings declined 62.2%
Comparative Analysis Report
WallStSmart ResearchBull Case : AHG
The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.
Bull Case : EDAP
EDAP has a balanced fundamental profile.
Bear Case : AHG
The primary concerns for AHG are Revenue Growth, EPS Growth, Market Cap.
Bear Case : EDAP
The primary concerns for EDAP are Market Cap, PEG Ratio, Return on Equity.
Key Dynamics to Monitor
AHG profiles as a value stock while EDAP is a turnaround play — different risk/reward profiles.
EDAP carries more volatility with a beta of -0.17 — expect wider price swings.
EDAP is growing revenue faster at 6.0% — sustainability is the question.
AHG generates stronger free cash flow (3M), providing more financial flexibility.
Bottom Line
AHG scores higher overall (24/100 vs 23/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Akso Health Group ADR
HEALTHCARE · MEDICAL DISTRIBUTION · China
Akso Health Group ADR is a leading entity in the healthcare sector, focused on delivering innovative medical solutions and integrated patient care services. With a specialization in advanced health technologies, the company is well-positioned to tap into growth opportunities in telehealth and personalized medicine, bolstered by a strong commitment to research and development. Its robust business model and dedication to quality, supported by a skilled team of professionals, make Akso Health Group an appealing investment for institutional investors aiming to navigate the transformative landscape of healthcare.
Visit Website →EDAP TMS SA
HEALTHCARE · MEDICAL DISTRIBUTION · USA
EDAP TMS SA, develops, produces, markets, distributes and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States and internationally. The company is headquartered in Lyon, France.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?